12th Kumamoto AIDS Seminar Global COE Joint International Symposium
 
Poster Session   *Dawnload ¨PDF
     
October 20th, Thursday    
Session 1: 12:40-14:20 Odd numbers 12:40-13:20, Even numbers 13:20-14:00, Free time14:00-14:20@
Session 2: 18:10-19:00 Free time  
     
October 21th, Friday    
Session 3: 11:40-13:20 Free time  
     
©Program    

Poster
No.
Presenter Title
P-01 Yutaka Takebe
[NIID, Japan / NCAIDS/STD China]
Reconstructing the epidemic history of HIV-1 subtype B' that is responsible for explosive blood-borne epidemics in Asia: its public health implications and the relevance for future vaccine strategies

P-02 Atsushi Koito
[Kumamoto Univ.]
Retrovirus, retroelement restrictions by APOBEC enzymes

P-03 Tetsuo Narumi
[Tokyo Medical and Dental Univ.]
SAR study of small molecular CD4 mimics targeting the dynamic supramolecular mechanism of HIV entry and their hybrid molecules with a CXCR4 antagonist

P-04 Manabu Aoki
[Kumamoto Health Science Univ.]
Identification of amino acid substitutions associated with compromized tipranavir’s dimerization inhibition and enzymatic inhibition

P-05 Kazuhiko Maeda
[Kumamoto Univ.]
GANP promotes APOBEC3G encapsidation in virions to reduce viral infectivity

P-06 Koichi Hamada
[Kumamoto Univ.]
Critical Role of the PI3K/PTEN/GSK-3 Signaling Pathway in HIV latent infected cells

P-07 Takeo Kuwata
[Kumamoto Univ.]
Biased induction of neutralizing antibodies with particular specificity and gene usage in SIVsmH635FC-infected macaques

P-08 Kazuaki Monde
[Kumamoto Univ.]
Coassembly of HERV-K Gag with HIV-1 Gag

P-09 Nobuyo Higashi-Kuwata
[Kumamoto Univ.]
Alteration of the dynamics of HIVmc dissemination in huPBMC NOJ mice under Raltegravir administration

P-10 Tsunefusa Hayashida
[NCGM/Kumamoto Univ.]
Trends in early and late diagnosis of HIV infection analyzed by BED assay

P-11 Koji Watanabe
[NCGM/Kumamoto Univ.]
Clinical and epidemiological features of amebiasis in HIV-1-infected Japanese men

P-12 Takeshi Nishijima
[NCGM/Kumamoto Univ.]
Renal function declines more with tenofovir use than abacavir among low-body weight treatment-naïve patients with HIV infection

P-13 Atsuko Hachiya
[NCGM]
HIV-1 Reverse Transcriptase (RT) Polymorphism 172K, Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Nonnucleoside RT Inhibitors

P-14 Shigeyoshi Harada
[Kumamoto Univ.]
Impact of raltegravir pressure on the selection of HIV-1 envelope sequences in vitro

P-15 Hiromi Terasawa
[Kumamoto Univ.]
A single amino acid mutation in V3 loop of a CRF01_AE HIV-1 responsible for reversion of dual-X4 to dual-R5 HIV-1 by a CXCR4 antagonist in vitro

P-16 Yusuke Nakano
[Kumamoto Univ.]
The impact of enhanced CCR5 homo-oligomerization by CCR5 inhibitors on HIV-1 infection

P-17 Tomofumi Nakamura
[Kumamoto Univ.]
Visualization and quantification of the multimer formation of HIV-1 integrase using biomolecular fluorescent complementation (BiFC)

P-18 Masayuki Amano
[Kumamoto Univ.]
A Novel Oxatricyclic-ligand-Containing Nonpeptidic Protease Inhibitor (PI) GRL-0519A Potent against Multi-PI-Resistant HIV In Vitro

P-19 Hiroshi Arai
[Tokyo Medical and Dental Univ.]
Design, synthesis and biological evaluation of CD4 mimics targeting the interaction with Asp368 and Val430 in gp120

P-20 Kazuo Suzuki
[St Vincent's Centre for Applied Medical Research, Australia]
Sequence specific induction of HIV-1 transcriptional gene silencing targeting NF-kB sequences by siRNA without any off-target effects of other NF-B driven genes

P-21 Eriko Kudo
[Kumamoto Univ.]
Inhibition of HIV-1 replication by photo-degrading a fullerene-sugar hybrids

P-22 Ryusho Kariya
[Kumamoto Univ.]
HIV protease inhibitor inhibits the growth of primary effusion lymphoma and induces apoptosis

P-23 Kouki Matsuda
[Kumamoto Univ.]
Cepharanthine controls HIV-1 infection by inhibiting the fusion of virus

P-24 Masako Shimamoto
[Kumamoto Univ.]
Inhibition of Cell Cycle Progression by Proton Pump Inhibitor in Primary Effusion Lymphoma

P-25 Peter Gee
[Kyoto Univ.]
Biochemical characterization of the HIV-1 restriction factor SAMHD1

P-26 Ken Kono
[Osaka Univ.]
Functional and geographical diversity of antiretroviral host factor TRIMCyp in Cynomolgus macaque (Macaca fascicularis)

P-27 Nopporn Chutiwitoonchai
[Kumamoto Univ.]
Interferon-inducible IFITM family proteins reduce HIV-1 production

P-28 Hasan Md. Zafrul
[Kumamoto Univ.]
Subtle effect of HLA class I-driven selective forces on the variability of HIV-1 accessory genes

P-29 Philip Mwimanzi
[Kumamoto Univ.]
Population analysis of viral replication capacity by nef alleles of HIV elite controllers

P-30 Michihiro Hashimoto
[Kumamoto Univ.]
Activation of brain microglial cells by extracellular HIV-1 Nef proteins

P-31 Masateru Hiyoshi
[Kumamoto Univ.]
HIV-1 Nef Perturbs the Function, Structure, and Signaling of the Golgi through the Src Kinase Hck

P-32 Takashi Chihara 
[Kumamoto Univ.]
Preferential activation of anti-inflammatory M2-type macrophages by HIV-1 proteins

P-33 Katsuhiro Io
[Kyoto Univ.]
Phosphorylation of p53 is enhanced by HIV-1 Vif and required for Vif-induced G2 cell cycle arrest and apoptosis

P-34 Pattaravadee Srikoon
[Kumamoto Univ.]
Dual NK activities in minor subpopulation, CD56dimCD16- NK cells in cord blood and periphery and its association with NK defects in HIV-1-infection

P-35 Manthana Mitchai
[Khon Kean Hospital, Thailand]
Function and characterization of CD56-/CD16+ natural killer cell in viremic and treated aviremic HIV infected patient

P-36 Shinichiro Hattori 
 [Kumamoto Univ.]
Expansion of Human CD3-CD56+ NK Cells and HIV-1 Infection in NOD/SCID/Jak3-/- Mouse

P-37 Chihiro Motozono
[Cardiff Univ., UK]
The cross-reactivity footprints of HIV-specific CTLs

P-38 Nozomi Kuse 
[Kumamoto Univ.]
Selection of Pol283-8V mutant by Pol283-8-specific CTLs in long-term non progressors of HLA-B*51:01+Japanese hemophiliacs

P-39 Hayato Murakoshi
[Kumamoto Univ.]
Comprehensive analysis of HIV-1-specific CD8+ T cell responses in chronically HIV-1 clade B-infected Japanese cohort

P-40 Tomohiro Akahoshi
[Kumamoto Univ.]
Role of cross-reactive CTLs in selection of HIV-1escape mutant

P-41 Takayuki Chikata
[Kumamoto Univ.]
HLA-Associated Viral Polymorphism in Chronically HIV-1-Infected Japanese Cohort

P-42 Yasuhiro Maruta
[Kumamoto Univ.]
Construction of neutralizing antibody fragments for efficient access to V3 epitope

P-43 Kristel Ramírez
[Kumamoto Univ.]
Novel CD4-induced monoclonal antibodies (MAbs) with cross-neutralizing activity against primary isolates of HIV-1 B and C subtypes

P-44 Teppei Toda 
[Kumamoto Univ.]
Dynamic changes in antigenic membrane fusion epitopes initiated by interactions between HIV-1 envelope proteins and CD4/CXCR4

P-45 Kyoko Kurihara
[NIID/Univ. of Tokyo]
Combination of intranasal and intramuscular Sendai virus vector immunization

P-46 Yusuke Takahara
[NIID/Univ. of Tokyo]
Impact of therapeutic vaccination during HAART on CTL immunodominance in SIV infection

P-47 Masayuki Ishige
[NIID/Kumamoto Univ.]
Analysis of dominantly replicated virus in the acute phase by X4-type and/or R5-type HIV-1 infection in humanized NOD/SCID/Jak3-null mice

P-48 Hiromi Ogata-Aoki
[Kumamoto Univ.]
Early Phase Dynamics of HIV Infection in hPBMC-Transplanted NOD/SCID/Jak3-/- Mice Using Infectious HIV Carrying a Fluorescent Protein, mCherry

P-49 Yoshinori Sato
[Kumamoto Univ.]
Elicitation of human effector CD8+ T cells in HIV-1-infected HLA-B*51:01 transgenic humanized mice
   
©Program